09:00 | Welcome & Introductions | |||
09:02 | Markers of RPE Inflammation in AMD development | KLETTNER A | ||
09:12 | Anti-drug antibodies to brolucizumab as potential risk factors for ocular inflammation | BUSCH M | ||
09:22 | OCT-Biomarkers in uveitic macular edema | WINTERGERST M | ||
09:32 | Biomarkers in White-dot-Syndromes | POHLMANN D | ||
09:42 | Biomarkers of the anterior chamber to predict complicated courses in uveitis | HEINZ C | ||
09:52 | Discussions and Closing Remarks | |||
10:00 | End of Session |